Arbutus Biopharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ABUS and other ETFs, options, and stocks.

About ABUS

Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the Hepatitis B virus, SARS-CoV-2, and other coronaviruses. 

CEO
Michael J. McElhaugh
CEOMichael J. McElhaugh
Employees
73
Employees73
Headquarters
Warminster, Pennsylvania
HeadquartersWarminster, Pennsylvania
Founded
2005
Founded2005
Employees
73
Employees73

ABUS Key Statistics

Market cap
493.68M
Market cap493.68M
Price-Earnings ratio
-6.27
Price-Earnings ratio-6.27
Dividend yield
—
Dividend yield—
Average volume
1.06M
Average volume1.06M
High today
$2.81
High today$2.81
Low today
$2.71
Low today$2.71
Open price
$2.75
Open price$2.75
Volume
348.06K
Volume348.06K
52 Week high
$3.29
52 Week high$3.29
52 Week low
$1.69
52 Week low$1.69

ABUS News

TipRanks 7d
Arbutus Biopharma Announces Q1 2024 Financial Update - TipRanks.com - TipRanks

Arbutus Biopharma (ABUS) has released an update. Arbutus Biopharma Corporation, a company focused on developing treatments for chronic hepatitis B, is set to a...

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.